BSEOthers1 Sept 2026 · 1 Sept 2026, 04:04 pm
We hereby informed that Board of Directors of the Company at its meeting held on Tuesday, the 01st September, 2026 discuss the agenda attached herewith.
iSERA Lifesciences Ltd · 534920
✦ AI SummaryResults
iSERA Lifesciences Ltd has informed about the outcome of its Board Meeting held on September 1, 2026, where the Board approved the notice for the 34th Annual General Meeting, audited standalone financial statements for FY 2025-26, and the Annual Report for FY 2025-26.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
iSERA Lifesciences Ltd - 534920 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 01.09.2026 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Attachments (1)
📄pdf
Download →
40ff1656-710f-41b0-9b18-e884c38f5f14.pdf
View document text
iSERA LIFESCIENCES LIMITED
iSERA R .
(For ly knowna s Goxidh. Te L d)
CIN: 172200PN
Date: 01.09.2026
The Secretary
Department Of Corporate Services
Bombay Stock Exchange Limited
Floor 25, Phiroze Jeejeebhoy Tower, Dalal
Street, Mumbai-400 oo1
BSE Scrip Code: 534920
Subject: Outcome of the Board Meeting held today on 01.09.2026 under Regulation 30 of SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015
Dear Sir/Madam,
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements),
Regulations 2015, the Board of Directors of the Company at its meeting held on Tuesday, the o1t September,
2026 held via video conferencing which commenced at 3.30 P.M. and concluded at 04:00 P.M. consider and
approve:
1. Fixed the day, date, time and mode, and approved the Notice to be sent to the members of the Company
and the Stock Exchange for convening the 34th Annual General Meeting of the Company for the
Financial Year 2025-26, scheduled to be held on Tuesday, September 29, 2026, at 3 P.M. (IST) through
Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”), to receive, consider and adopt the
audited standalone financial statements of the company for the financial year ended 31st march, 2026,
and the reports of the board of director’s and auditor’s thereon;
2. The Annual Report of the Company for the Financial Year 2025-26, including the Director’s Report and
its Annexures, for the financial year ended 31st March, 2026.
3. The appointment of Scrutinizer for the Annual General Meeting of the Company; M/s. Anuj Gupta &
Associates, Company Secretaries, have been appointed as the Scrutinizer for remote e-voting/e-voting
at the time of 34t Annual General Meeting of the Company.
You are requested to take the above information on records.
Thanking you,
Yours faithfully,
Office No. A1-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pune — 411001
Tel: 4918329012053 + Email: cscovidh@gmail.com + Website: www.covidhtechnologies.com
iSERA LIFESCIENCES LIMITED
CIN: L72200PN1993PLC252720
On the behalf of the Board of Directors
iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited)
Company Secretary Cum Compliance Officer
Deepakshi
MEM. NO.: A76335
Office No. A1-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pu— 4n110e01
Tel: 4918329012053 + Email: cscovidh@gmail.com + Website: www.covidhtechnologies.com